The Scientific Research Team at Abalos Therapeutics is responsible for developing and optimizing novel immuno-virotherapies for cancer treatment. This team conducts in vivo immune-oncology studies, engages in bioprocess development, and collaborates across various scientific disciplines to advance therapeutic candidates from discovery through preclinical development.